173 related articles for article (PubMed ID: 17084795)
21. Access to medical care, use of preventive services, and chronic conditions among adults in substance abuse treatment.
Benjamin-Johnson R; Moore A; Gilmore J; Watkins K
Psychiatr Serv; 2009 Dec; 60(12):1676-9. PubMed ID: 19952160
[TBL] [Abstract][Full Text] [Related]
22. Treatment programs in the National Drug Abuse Treatment Clinical Trials Network.
McCarty D; Fuller B; Kaskutas LA; Wendt WW; Nunes EV; Miller M; Forman R; Magruder KM; Arfken C; Copersino M; Floyd A; Sindelar J; Edmundson E
Drug Alcohol Depend; 2008 Jan; 92(1-3):200-7. PubMed ID: 17875368
[TBL] [Abstract][Full Text] [Related]
23. Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study.
Martel-Laferrière V; Nitulescu R; Cox J; Cooper C; Tyndall M; Rouleau D; Walmsley S; Wong L; Klein MB;
BMC Infect Dis; 2017 Jan; 17(1):80. PubMed ID: 28095797
[TBL] [Abstract][Full Text] [Related]
24. Medical clinic characteristics and access to behavioral health services for persons with HIV.
Ohl ME; Landon BE; Cleary PD; LeMaster J
Psychiatr Serv; 2008 Apr; 59(4):400-7. PubMed ID: 18378839
[TBL] [Abstract][Full Text] [Related]
25. Identifying Barriers to the Treatment of Chronic Hepatitis C Infection.
Al-Khazraji A; Patel I; Saleh M; Ashraf A; Lieber J; Malik R
Dig Dis; 2020; 38(1):46-52. PubMed ID: 31422405
[TBL] [Abstract][Full Text] [Related]
26. The Hepatitis C Awareness Through to Treatment (HepCATT) study: improving the cascade of care for hepatitis C virus-infected people who inject drugs in England.
Harrison GI; Murray K; Gore R; Lee P; Sreedharan A; Richardson P; Hughes AJ; Wiselka M; Gelson W; Unitt E; Ratcliff K; Orton A; Trinder K; Simpson C; Ryder SD; Oelbaum S; Foster GR; Christian A; Smith S; Thomson BJ; Reynolds R; Harris M; Hickman M; Irving WL
Addiction; 2019 Jun; 114(6):1113-1122. PubMed ID: 30694582
[TBL] [Abstract][Full Text] [Related]
27. Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic.
Gelkopf M; Weizman T; Melamed Y; Adelson M; Bleich A
Isr J Psychiatry Relat Sci; 2006; 43(2):126-36. PubMed ID: 16910375
[TBL] [Abstract][Full Text] [Related]
28. Correlates of drug use cessation among participants in the Canadian HIV-HCV Co-infection Cohort.
Cox J; Maurais E; Hu L; Moodie EE; Law S; Bozinoff N; Potter M; Rollet K; Hull M; Tyndall M; Cooper C; Gill J; Saeed S; Klein MB;
Drug Alcohol Depend; 2014 Apr; 137():121-8. PubMed ID: 24559606
[TBL] [Abstract][Full Text] [Related]
29. The prevalence of mental and physical health disorders among older methadone patients.
Rosen D; Smith ML; Reynolds CF
Am J Geriatr Psychiatry; 2008 Jun; 16(6):488-97. PubMed ID: 18515693
[TBL] [Abstract][Full Text] [Related]
30. [Characteristics of heroin dependent patients admitted to a methadone treatment program].
Sanvisens A; Rivas I; Faure E; Muñoz T; Rubio M; Fuster D; Tor J; Muga R
Med Clin (Barc); 2014 Jan; 142(2):53-8. PubMed ID: 23337454
[TBL] [Abstract][Full Text] [Related]
31. Influence of comorbid drug use disorder on receipt of evidence-based treatment for alcohol use disorder among VA patients with alcohol use disorder and Hepatitis C and/or HIV.
Frost MC; Matson TE; Tsui JI; Williams EC
Drug Alcohol Depend; 2019 Jan; 194():288-295. PubMed ID: 30469100
[TBL] [Abstract][Full Text] [Related]
32. Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users.
Roux P; Fugon L; Winnock M; Salmon-Céron D; Lacombe K; Sogni P; Spire B; Dabis F; Carrieri MP;
Addiction; 2012 Jan; 107(1):152-9. PubMed ID: 21819472
[TBL] [Abstract][Full Text] [Related]
33. Integrating care for hepatitis C virus (HCV) and primary care for HIV for injection drug users coinfected with HIV and HCV.
Kresina TF; Bruce RD; Cargill VA; Cheever LW
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S83-8. PubMed ID: 16265621
[TBL] [Abstract][Full Text] [Related]
34. Barriers to treatment of hepatitis C in HIV/HCV-coinfected adults with alcohol problems.
Nunes D; Saitz R; Libman H; Cheng DM; Vidaver J; Samet JH
Alcohol Clin Exp Res; 2006 Sep; 30(9):1520-6. PubMed ID: 16930214
[TBL] [Abstract][Full Text] [Related]
35. Twin epidemics of new and prevalent hepatitis C infections in Canada: BC Hepatitis Testers Cohort.
Janjua NZ; Yu A; Kuo M; Alvarez M; Cook D; Wong J; Tyndall MW; Krajden M
BMC Infect Dis; 2016 Jul; 16():334. PubMed ID: 27436414
[TBL] [Abstract][Full Text] [Related]
36. Alcohol consumption upon direct-acting antiviral therapy for hepatitis C among persons with human immunodeficiency virus in the United States.
Chen PH; Yenokyan K; Fojo AT; Hutton HE; Lesko CR; McCaul ME; Yang C; Cachay ER; Crane HM; Jacobson JM; Kim HN; Kitahata MM; Mayer KH; Moore RD; Napravnik S; Saag M; Lau B; Chander G
Drug Alcohol Depend; 2022 Dec; 241():109673. PubMed ID: 36332596
[TBL] [Abstract][Full Text] [Related]
37. Systematic services audit of consecutive suicides in New Brunswick: the case for coordinating specialist mental health and addiction services.
Lesage A; Séguin M; Guy A; Daigle F; Bayle MN; Chawky N; Tremblay N; Turecki G
Can J Psychiatry; 2008 Oct; 53(10):671-8. PubMed ID: 18940035
[TBL] [Abstract][Full Text] [Related]
38. The MICA Case Conference Program at Tewksbury Hospital, Mass.: an integrated treatment model.
Clodfelter RC; Albanese MJ; Baker G; Domoto K; Gui AL; Khantzian EJ
Am J Addict; 2003; 12(5):448-54. PubMed ID: 14660158
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C testing and treatment among active drug users in Amsterdam: results from the DUTCH-C project.
Lindenburg CE; Lambers FA; Urbanus AT; Schinkel J; Jansen PL; Krol A; Casteelen G; van Santen G; van den Berg CH; Coutinho RA; Prins M; Weegink CJ
Eur J Gastroenterol Hepatol; 2011 Jan; 23(1):23-31. PubMed ID: 21042221
[TBL] [Abstract][Full Text] [Related]
40. Improving access to geriatric mental health services: a randomized trial comparing treatment engagement with integrated versus enhanced referral care for depression, anxiety, and at-risk alcohol use.
Bartels SJ; Coakley EH; Zubritsky C; Ware JH; Miles KM; Areán PA; Chen H; Oslin DW; Llorente MD; Costantino G; Quijano L; McIntyre JS; Linkins KW; Oxman TE; Maxwell J; Levkoff SE;
Am J Psychiatry; 2004 Aug; 161(8):1455-62. PubMed ID: 15285973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
